
Few studies have examined the importance of socioeconomic risk factors on overall health.

Few studies have examined the importance of socioeconomic risk factors on overall health.

Synjardy has received FDA approval for an expanded indication to include treatment-naïve adults with type 2 diabetes

The characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.

Diabetes-related deaths account for up to 12% of overall deaths.

The American Diabetes Association releases an update position statement reflecting the current diabetic neuropathy landscape.

Inhibiting theIPK61 protein was observed to stop weight gain in animals.

Researchers worked to develop a new statement for the prevention, management, and treatment of diabetic neuropathy.

Diabetes may develop or worsen with early-stage pancreatic cancer.

Onset or rapid deterioration of diabetes may be an indicator of hidden pancreatic cancer.

Label now includes the use of dulaglutide in combination with basal insulin in adults with type 2 diabetes.

Association found between medically appropriate food support and improved HIV and diabetes health.

Comprehensive nutrition could improve the overall health of patients with chronic diseases.

Health initiatives should aim to prevent weight gain in order to avert new cases of diabetes.

Top 5 tips for managing diabetes on Valentine’s Day.

The key to keeping blood sugar levels safely maintained may be found within intracellular changes to some brain cells.

Internalizing weight bias can lead to unhealthy behaviors and high levels of triglycerides.

Evidence-based medicine may improve treatment for diabetes.

Patients with severe mental illnesses avoidably die much sooner than general population.

Obesity blamed for the tendency of diabetes patients to develop osteoarthritis.

Physical exercise has long been shown to have positive benefits for patients with type 1 and type 2 diabetes.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Eli Lilly’s type 2 diabetes drug, Trulicity (dulaglutide), has updated its label, discussing use in combination with basal insulin for adults with type 2 diabetes to achieve greater blood sugar control.

Obesity-related diabetes is transforming into a global health crisis that is no longer limited to developed countries.

The STAND program prevents avoidable hospitalizations by providing type 1 diabetes information in 3 sessions.